Dominique Spaëth

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, C. Bourgier, Claire Cropet et al. · Journal of Clinical Oncology · 2012 · 709 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Stephen Johnston, Semiglazov Vf, George Manikhas et al. · Breast Cancer Research and Treatment · 2007 · 62 citations

Medicine, Oncology, Pharmacology +14

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group

C. Hober, Lisa Fredeau, Anne Pham‐Ledard et al. · Cancers · 2021 · 57 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.

François‐Clément Bidard, Céline Callens, Florence Dalenc et al. · Journal of Clinical Oncology · 2020 · 50 citations

Medicine, Oncology, Pharmacology +15

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study

Joseph Gligorov, Xavier Pivot, William Jacot et al. · The Oncologist · 2015 · 45 citations · Full text

Medicine, Endocrinology, Oncology +17